Information Provided By:
Fly News Breaks for June 15, 2016
UTHR
Jun 15, 2016 | 07:07 EDT
H.C. Wainwright analyst Andrew Fein downgraded United Therapeutics to Neutral saying he sees no short-term drivers of growth and "multiple indicators" of commercial, corporate, and IP weakness. The analyst cut his price target for the shares to $95 from $175.
News For UTHR From the Last 2 Days
There are no results for your query UTHR